UNSPSC 85541827: Removal of autologous tissue substitute from cisterna chyli, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of autologous tissue substitute from cisterna chyli, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07PL37Z

UNSPSC 85541827 Removal of autologous tissue substitute from cisterna chyli, percutaneous approach is a Commodity code that does not align with recent state and local procurement activity. The code nominally describes a specific surgical procedure involving removal of autologous tissue substitute from the cisterna chyli using percutaneous approach — a narrow medical intervention. However, the state and local contract opportunities posted under this code in recent months do not involve this procedure or related surgical services. Instead, the opportunities span occupational medical surveillance, independent medical evaluation services for pension disability determinations, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-out benefit programs for municipal employees, and information requests for emergency and specialty medical care for detained youth. None of these solicitations address the removal of autologous tissue substitutes or the specific procedural scope the Commodity code describes.

The mismatch suggests the code is either incorrectly applied to these opportunities in source data, or the opportunities have been broadly tagged with a medical-procedure code that does not reflect their actual scope of work. No recent state and local contract opportunities specifically target the procedure named in UNSPSC 85541827. State and local procurement professionals evaluating this code should verify the code assignment against actual scope requirements before pursuing opportunities posted under this classification, as the current opportunity set does not reflect the Commodity's nominal medical-procedure focus.